Journal
APPLIED RADIATION AND ISOTOPES
Volume 122, Issue -, Pages 222-228Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.apradiso.2017.01.035
Keywords
astatine-211; At-211; astatine-209; At-209; radon-211; radon-211; francium; radioisotope production; generator system; targeted alpha therapy; ISOL-technique, rare isotope beam; ion implantation
Categories
Funding
- Innovation Grant from the Canadian Cancer Society Research Institute [702437]
Ask authors/readers for more resources
Mass-separated francium beams (Fr-211 or Fr-213) were implanted into solid targets for producing Rn-211 (14.6 h half-life) or At-209 (5.41 h), in situ. Rn-211 was transferred to dodecane and isolated from contaminants, providing sources for At-211 (7.21 h) production by Rn-211 decay (73%). At-209 was recovered with high radionuclidic purity in aqueous solutions, directly. These experiments demonstrated Fr beam implantations as a novel method for producing preclinical quantities of Rn-211/(211) Fit (for therapy) and At-209 (for imaging).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
